Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Haemonetics Corp shares valued at $98,784 were purchased by KROLL MARK W on Nov 10 ’25. At $70.56 per share, KROLL MARK W acquired 1,400 shares. The insider’s holdings grew to 24,757 shares worth approximately $1.81 million following the completion of this transaction.
Also, Llorens Josep purchased 18,630 shares, netting a total of over 1,396,132 in proceeds.
Before that, Strong Stewart W had added 708 shares to its account. In a trade valued at $50,593, the Former Officer bought Haemonetics Corp shares for $71.46 each.
As published in a research note from Raymond James on August 11, 2025, Haemonetics Corp [HAE] has been rated down from a Strong buy to an Outperform and the price target has been revised to $78. Analysts at Barrington Research resumed the stock at ‘”an Outperform”‘ outlook in a report released in early August. As of August 08, 2025, JP Morgan has decreased its “an Overweight” rating to a “Neutral” for HAE. Earlier on July 09, 2025, Citigroup upgraded its rating. Their new recommendation was “a Buy” for HAE stock which previously was a “a Neutral”.
Analyzing HAE Stock Performance
On last trading session, Haemonetics Corp [NYSE: HAE] rose 1.94% to $73.12. The stock’s lowest price that day was $71.48, but it reached a high of $74.17 in the same session. During the last five days, there has been a surge of approximately 44.16%. Over the course of the year, Haemonetics Corp shares have dropped approximately -16.36%. Shares of the company reached a 52-week high of $82.25 on 01/15/25 and a 52-week low of $47.31 on 09/26/25.
Support And Resistance Levels for Haemonetics Corp (HAE)
According to the 24-hour chart, there is a support level at 71.67, which, if violated, would cause prices to drop to 70.22. In the upper region, resistance lies at 74.38. The next price resistance is at 75.64. RSI (Relative Strength Index) is 88.69 on the 14-day chart, showing overbought technical sentiment.
Is Haemonetics Corp subject to short interest?
Stocks of Haemonetics Corp saw a sharp steep in short interest on 2025-10-31 dropping by 9863.0 shares to 3.12 million. Data from Yahoo Finance shows that the short interest on 2025-09-30 was 3.13 million shares. A decline of -0.32% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 4.84 of the overall float, the days-to-cover ratio (short ratio) decline to 4.84.
Which companies own the most shares of Haemonetics Corp (HAE)?
In terms of Haemonetics Corp share price expectations, FactSet research, analysts set an average price target of 78 in the next 12 months, up nearly 8.74% from the previous closing price of $71.73. Analysts anticipate Haemonetics Corp stock to reach 88 by 2025, with the lowest price target being 68. In spite of this, 4 analysts ranked Haemonetics Corp stock as Buy at the end of 2025. On June 26, 2025, Robert W. Baird assigned a price target of “an Outperform” to the stock and initiated coverage with a $87.
